Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000405394

Medchemexpress LLC Olsalazine (disodium) | 6054-98-4 | 99.8% | 10 G
SDP

Catalog No. 5000405394
Encompass_Preferred

Olsalazine Disodium is an orally active prodrug of 5-ASA. It is utilized in research for cancer, inflammation, and metabolic diseases, including colorectal cancer, inflammatory bowel disease (IBD), and hyperuricemia. This compound can inhibit cell proliferation, induce apoptosis, reduce DAI and MPO activity, and inhibit inflammatory cytokine levels.

  • Orally active prodrug of 5-ASA
  • Inhibits cell proliferation
  • Induces apoptosis
  • Reduces DAI and MPO activity
  • Inhibits inflammatory cytokine levels
  • Suitable for research in cancer
  • Suitable for research in inflammation
  • Suitable for research in metabolic diseases

Catalog No. 50-004-05394 Supplier Medchemexpress LLC Supplier No. HYB017410G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Olsalazine Disodium is an orally active prodrug of 5-ASA. It is utilized in research for cancer, inflammation, and metabolic diseases, including colorectal cancer, inflammatory bowel disease (IBD), and hyperuricemia. This compound can inhibit cell proliferation, induce apoptosis, reduce DAI and MPO activity, and inhibit inflammatory cytokine levels.

  • Orally active prodrug of 5-ASA
  • Inhibits cell proliferation
  • Induces apoptosis
  • Reduces DAI and MPO activity
  • Inhibits inflammatory cytokine levels
  • Suitable for research in cancer
  • Suitable for research in inflammation
  • Suitable for research in metabolic diseases

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.